Assessment of mitochondrial toxicity in human cells treated with tenofovir: comparison with other nucleoside reverse transcriptase inhibitors

G Birkus, MJM Hitchcock, T Cihlar - Antimicrobial agents and …, 2002 - Am Soc Microbiol
Drug-associated dysfunction of mitochondria is believed to play a role in the etiology of the
various adverse symptoms that occur in human immunodeficiency virus (HIV)-infected …

Mitochondrial toxicity of tenofovir, emtricitabine and abacavir alone and in combination with additional nucleoside reverse transcriptase inhibitors

N Venhoff, B Setzer, K Melkaoui… - Antiviral therapy, 2007 - journals.sagepub.com
Background Some nucleoside/nucleotide reverse transcriptase inhibitor (NRTI)
combinations cause additive or synergistic interactions in vitro and in vivo. Methods We …

Antiretroviral nucleoside and nucleotide analogues and mitochondria

A Cossarizza, G Moyle - Aids, 2004 - journals.lww.com
This review is intended to provide understanding of the function of mitochondria, the
advantages and disadvantages of available techniques for assessing mitochondrial function …

Mitochondrial dysfunction and nucleoside reverse transcriptase inhibitor therapy: experimental clarifications and persistent clinical questions

W Lewis - Antiviral research, 2003 - Elsevier
Nucleoside reverse transcriptase inhibitors (NRTIs) in combination with other antiretrovirals
(HAART) are critical in current AIDS therapy, but mitochondrial side effects have come to …

Mitochondrial toxicity and HIV therapy

AJ White - Sexually transmitted infections, 2001 - sti.bmj.com
Nucleoside reverse transcriptase inhibitors (NRTIs) remain the cornerstone of highly active
antiretroviral therapy (HAART) combination regimens. However, it has been known for some …

[HTML][HTML] Tenofovir-induced kidney disease: an acquired renal tubular mitochondriopathy

MA Perazella - Kidney international, 2010 - Elsevier
Tenofovir, used in combination with other antiretroviral agents, is an effective therapy for HIV
infection. Although large clinical studies and post-marketing data support a benign renal …

An introduction to nucleoside and nucleotide analogues

KE Squires - Antiviral therapy, 2001 - journals.sagepub.com
The introduction of newer and more potent agents has diverted attention away from the
importance of nucleoside analogue reverse transcriptase inhibitors (NRTIs) in modern …

Mitochondrial dysfunction and antiretroviral nucleoside analog toxicities: what is the evidence?

T Dagan, C Sable, J Bray, M Gerschenson - Mitochondrion, 2002 - Elsevier
Mitochondrial dysfunction has been associated with long-term toxicities of human
immunodeficiency virus (HIV) therapy, particularly with the nucleoside analog reverse …

Exploring mitochondrial nephrotoxicity as a potential mechanism of kidney dysfunction among HIV-infected patients on highly active antiretroviral therapy

HCF Côté, AB Magil, M Harris, BJ Scarth… - Antiviral …, 2006 - journals.sagepub.com
Background Tenofovir (TDF) exposure has been associated with renal dysfunction.
Mitochondrial nephrotoxicity was investigated as an underlying mechanism. Given the …

Pharmacology of nucleoside and nucleotide reverse transcriptase inhibitor-induced mitochondrial toxicity

TN Kakuda - Clinical therapeutics, 2000 - Elsevier
OBJECTIVE: This paper reviews the function of the mitochondria and the mechanisms by
which nucleoside and nucleotide reverse transcriptase inhibitors (NRTIs) cause …